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The Valued Life Activities Scale (VLAs):
linguistic validation, cultural adaptation and
psychometric testing in people with
rheumatic and musculoskeletal diseases in
the UK
Y. Prior1* , A. Tennant2, S. Tyson3 and A. Hammond1
Abstract
Background: The Valued Life Activities Scale (VLAs) measures difficulty in daily activities and social participation.
With various versions involving a different number of items, we have linguistically and culturally adopted the full VLAs
(33-items) and psychometrically tested it in adults with rheumatic and musculoskeletal diseases in the United Kingdom.
Methods: Participants with Rheumatoid Arthritis, Ankylosing Spondylitis, Chronic Pain/ Fibromyalgia, Chronic Hand/
Upper Limb Conditions, Osteoarthritis, Systemic Lupus, Systemic Sclerosis and Primary Sjogren’s Syndrome were
recruited from out-patient clinics in National Health Service Hospitals, General Practice and patient organisations in the
UK. Phase1 involved linguistic and cultural adaptation: forward translation to British English; synthesis; expert panel
review and cognitive debriefing interviews. In Phase2 participants completed postal questionnaires to assess internal
construct validity using (i) Confirmatory Factor Analysis (CFA) (ii) Mokken scaling and (iii) Rasch model.
Results: Responders (n = 1544) had mean age of 59 years (SD13.3) and 77.2% women. A CFA failed to support a total
score from the 33-items (Chi Square 3552:df 464: p < 0.0001). Mokken scaling indicated a strong non-parametric
association between items. Fit to the Rasch model indicated that the VLAs was characterised by multidimensionality
and item misfit, which may have been influenced by clusters of residual item correlations. An item banking approach
resolved a 25-item calibrated set whose application could accommodate the ‘does not apply to me’ response option.
Conclusions: The UK version of the VLAs failed to satisfy classical and modern psychometric standards for complete
item sets. However, as the scale is not usually applied in complete format, an item bank approach calibrated 25 items
with fit to the Rasch model. Suitable Computer Adaptive Testing (CAT) software could implement the item set, giving
patients the choice of whether an item applies to them, or not.
Keywords: RMDs, PROMS, Participation, Activities, Leisure, Activities of daily living, Valued life activities, Rasch analysis,
Validity, Reliability, RMDs (rheumatic and musculoskeletal diseases), PROMS (patient reported outcome measures)
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Background
Rheumatic and musculoskeletal diseases (RMDs) such as
Osteoarthritis (OA), Rheumatoid Arthritis (RA), Chronic
Pain (CP) and Fibromyalgia (FM), are common, and
their prevalence is rising with the ageing population [1].
Many individuals with RMDs report moderate to high
pain and fatigue which can lead to activity limitation and
participation restriction, which affect Quality of Life (QoL)
[2–5]. Therefore, European League Against Rheumatism
(EULAR) recommendations for health professionals’ ap-
proach to pain management in inflammatory arthritis and
OA, emphasise pain is a complex and multifaceted experi-
ence. Treatment should be guided by patient’s preferences
and priorities, such as the impact on their activities and
participation, in order to facilitate improved health out-
comes [6]. Patient reported outcome measures (PROMs)
can be used to identify such preferences and priorities.
However, few include both activities and participation
items.
Developed in the United States (USA), the Valued Life
Activities scale (VLAs) is one such PROM, measuring
both difficulty in daily activities and participation in so-
ciety [7]. It was developed from the 75-item Activities
Enumeration Index [8] which was derived from content
analysis of diaries and telephone interviews with patients
with RA or OA [7, 9–11].
The VLAs is based on Verbrugge and Jette’s disable-
ment model [12]. This defines activity and participation
in three domains:
 Obligatory: required for survival and self-sufficiency,
such as eating, hygiene, walking and transport
 Committed: related to one’s principal social roles,
such as paid work, child and family care and
household responsibilities and
 Discretionary: engaged in for relaxation and
pleasure, such as socialising, exercise, leisure,
hobbies, religious activities, travel, volunteer work,
educational activities, gardening.
The VLAs developers have allocated items to these
three domains based on the model’s definitions [7]
(Additional File 1).
The VLAs has been used in over 10 cohort studies
with large numbers of people with RA and systemic
lupus erythematosus (SLE), but the way in which it has
been administered varies, with different studies using
different numbers of items (i.e. 33, 29, 26, 21, or 14
items) – see Additional Table 1); some items differing
between versions (depending on diagnosis), and several
different scoring methods being used. These methods in-
clude: the average difficulty score for all items and for
each of the three domains; the average score created by
adjusting scores if the person reports changing how they
perform the activity (e.g. use an assistive device, have
help, take more time or limit time performing), with item
scores being increased by one point if the score < 2 [13]; or
calculating (unadjusted) scores only for those items identi-
fied as important by the participant [7, 14]. Accordingly, we
requested the definitive version and scoring method from
the lead scale developer (Dr P. Katz). This was identified as
the 33-item version scored on a 4-point scale (0 = no diffi-
culty to 3 = unable to do). People are asked to record for
each item: whether it is not applicable to them (i.e. the per-
son does not normally perform the activity for reasons un-
related to their condition); their degree of difficulty
performing it; and whether the item is important to them
[13]. The overall score is then calculated as the mean of
only those items identified as both applicable and import-
ant. As a result, different respondents’ scores are based on
different numbers of items within the VLAs, as the
intention is to score only those activities which are “valued”
by participants.
Some psychometric testing has been conducted with
the 33-item and shorter versions, although with differing
scoring methods, demonstrating internal consistency
and test-retest reliability. The 14-item Short-VLAs, was
developed using Rasch analysis, and unidimensionality,
construct and concurrent validity have also been demon-
strated [15, 16]. However, the variability in how the tool
has been administered (differing numbers of items) and
scoring methods means there is currently limited evi-
dence for the reliability and validity of the 33-item
VLAs.
The VLAs, and the way in which is used, presents con-
siderable challenges to deliver a robust psychometric
analysis. For example, in the full 33-item set, respon-
dents may simply respond to an item saying ‘it is not
relevant to me’ then, in practice, a valid response may
arise from any combination of the 33 items. As such,
there are a vast number of possible combinations available
(33 factorial). The current practice is to average the re-
sponses to the chosen items, giving a total score in the
range 0–3. There are two major problems with this ap-
proach; the responses are ordinal and do not support
mathematical operations such as averaging, which re-
quires at least interval scaling. Even if this is unfortunately
ignored, such averaging would only be interpretable if
every item had the same level of difficulty. Neither of these
conditions hold for items in ordinal scales [17, 18].
How then can a scale such as the VLAs be shown to
be psychometrically sound? To satisfy traditional psy-
chometric standards, the various items sets need to be
shown to be reliable, valid, unidimensional and invariant
for key groups (32). The items themselves need to be lo-
cally independent (conditional on the trait), although
failure of this requirement often reflects a degree of item
redundancy. The key issue here is that the item set, from
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which choices of relevant items are made, is robust from
a psychometric perspective.
Nevertheless, even if the various versions of the scale
are shown to be robust, there remains the challenge of
the scoring associated with, potentially, a very large
number of subsets as chosen by the user. It is here that
a variation of Computer Adaptive Testing (CAT) can re-
solve the issue. With a calibrated set of items (e.g. indi-
cating the level of difficulty associated with each of the
33 VLAs items), these can be administered to the re-
spondent, as long as there is a ‘not relevant for me’ op-
tion, which will be treated as a missing value by the
CAT, so moving on to the next item.
Consequently, the analytical strategy required is to first
assess the traditional psychometric properties of the
VLAs versions, and then proceed to determine if a cali-
brated item set suitable for CAT can be found, given any
limitations observed in the traditional analysis.
Before a PROM can be used in another language, or
country with the same language, it is necessary to adapt
the PROM and psychometrically test it in the target
group(s). Thus the aims of this study were to develop a
British English version of the VLAs (using the full 33-
item scale) following recommended linguistic and
cultural adaptation guidelines [19, 20], and to test its
psychometric properties in adults with RMDs in the
United Kingdom (UK). We also investigated the psycho-
metric properties of two shorter versions of the VLAs
(26 and 14-items), embedded within the 33-item defini-
tive version. The 26-item version, which had split the
‘physical activities’ item into two, but was included as
one item, as in the 33-item version, so making it, in
practice, a 25-item version, together with the 14-item
short form. Thus, the adaptation, and following psycho-
metric analysis focused on the 33, 26(25) and 14-item
versions.
Method
Study setting
Recruitment of people with RA was conducted through
rheumatology outpatient clinics in 17 National Health
Service (NHS) Hospitals. Participants with RA from a
previous PROM study were also contacted [21]. Recruit-
ment of people with the other seven RMDs was from 19
rheumatology or orthopaedic out-patient hospital de-
partments, four General Practitioner (GP) surgeries, and
from 10 RMD patient organisations in the UK.
Eligibility criteria
Inclusion criteria were people: aged ≥18 years; diagnosed
with Rheumatoid Arthritis (RA), Ankylosing Spondylitis
(AS), Chronic Pain (CP) or Fibromyalgia (FM), Chronic
Hand and Upper Limb Conditions (CHUL), Osteoarth-
ritis (OA), Systemic Lupus (SLE), Systemic Sclerosis
(SS), and Primary Sjogren’s Syndrome (PSS) by either a
rheumatology consultant, or an orthopaedic consultant, GP
or extended-scope health professional (in the case of OA
and CP/FM specifically); able to read, write and understand
English; and provide written informed consent.
Procedures
Phase-1: cross-cultural adaptation
We followed recommendations for linguistic and cross-
cultural adaptation [19, 20]. As the 33-item VLAs is
written in North American English, backward translation
was not required [Additional File 1]. Two native British
English speakers forward translated the VLAs; one of
whom was a rheumatology occupational therapist and
the other was not involved in health care and was un-
familiar with health outcome measures. Following for-
ward translation, the two translators resolved any
discrepancies. A North American speaker, with an aca-
demic background, also helped with checking that the
forward translation reflected the accurate meaning of
the item sets. An Expert Panel, consisting of three occu-
pational therapists, a physiotherapist, a methodologist
and a layperson with RA (all English speakers as their
first language) discussed the translation to agree a proto-
type British English VLAs. This was then reviewed by
the panel for semantic (i.e. do words mean the same
thing), idiomatic (e.g. presence of colloquialism or id-
ioms), experiential and conceptual equivalence to the
original 33-item North American English version of the
VLAs.
Cognitive de-briefing interviews
Cognitive de-briefing interviews were conducted with a
purposive sample of participants with RA identified from
the participants of a previous study residing within the
Midlands and North West of England [21]. The sample
included a wide range of demographic characteristics
and health status (i.e. range of age, gender, disease dur-
ation and work status). The questionnaire booklet was
posted for completion at home one week before a cogni-
tive de-briefing interview conducted face-to-face or by
telephone by an occupational therapist, depending on
the participant’s preference.
These semi-structured interviews determined whether
the VLAs items were relevant, understandable and com-
prehensive, and to confirm participants’ understanding
of the items matches the intended use [19]. Participants
were asked to rate the relevance and comprehensibility
of the VLAs using a five-point likert scale (1 = not rele-
vant to 5 = very relevant; and 1 = very easy to understand
to 5 = very difficult to understand). Interviews were
audio-recorded and transcribed for ease of content ana-
lyses. A preliminary report of the findings was reviewed
by the Expert Panel to agree on recommended changes
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prior to finalisation. A final version of this report and
the British English VLAs were submitted to the lead de-
veloper in the USA for review and the lead developer ap-
proved the changes.
Phase-2: psychometric testing
Participants Participants with one of the eight RMDs as
their primary diagnosis were recruited by research
nurses or therapists using an eligibility checklist to
screen patients. Additionally, patient organisations, such
as the National Rheumatoid Arthritis Society (NRAS),
Arthritis Care, National Ankylosing Spondylitis Society
(NASS) and Fibromyalgia Action UK (FMA UK), mailed
out study invitation letters, information sheets and a
reply form to random samples of their members to help
recruit participants. The reply form included the eligibil-
ity checklist items. Both rural and urban populations
and a wide mix of socio-demographic characteristics
were included (Fig. 1).
Data collection Data were collected using postal ques-
tionnaires. The questionnaire booklet included demo-
graphic and health data (e.g. age, gender, marital,
educational and employment status, disease duration,
medication regimen), the 33-item VLAs and two mea-
sures of physical function: the Health Assessment
Questionnaire (HAQ) [22], the SF36 v2.0 [23]; as well
as a 0–10 Numeric Rating Scale (NRS) reporting
disease activity.
Sample size
The sample size calculation for Rasch analysis suggested
that a sample of at least 150 for each condition will give
99% confidence of the person estimate being within ±0.5
logits, irrespective of whether or not the scale is well
targeted to the patients [24]. We chose to recruit a
higher number of people with RA as we aimed to con-
duct secondary analysis with the RA data, if the VLAs
demonstrated appropriate psychometric properties. We
stopped recruitment once we had at least 150 sufficiently
completed questionnaire booklets.
Statistical analysis
Confirmatory factor analysis
The VLAs has undergone revision over time, such that
there are several versions with 33- items being the de-
finitive version. The other versions are nested within the
33-item scale, but the 26-item version includes two
items for physical recreational activities (moderate and
vigorous), rather than one item, as in the 33-item VLAs.
Accordingly, when testing two shorter versions of the
VLAs, we derived a 25-item VLAs (rather than 26- item
version) from the 33-item version, as well as testing the
Short VLAs (SVLAs: 14 items).
Confirmation of the 33-item structure from a classical
test perspective would follow from a Confirmatory Fac-
tor Analysis (CFA) where a priori there is evidence that
the item set constitutes one, or a series of domains [25].
Following Kline, fit is determined by a non-significant
chi square statistic [26]. Ancillary fit statistics include
the RMSEA where a value less than 0.06 would be ap-
propriate, the Comparative Fit Index (CFI), a compari-
son of final model and baseline model, and the Tucker
Lewis Index (TLI), another incremental fit Index which
adds penalties for increasing the parameters. Both indi-
ces would suggest good fit with values above 0.95. Thus,
in the present study, the item set is fit to a CFA model
in Mplus [27] and tested for the three domains (Obliga-
tory, Committed and Discretionary) and the total score
only for “important and applicable” items.
Mokken scaling
The Mokken scale is a non-parametric probabilistic
model that utilises the Loevingers H coefficient to deter-
mine the ‘scalability’ of a set of items. H appears to be a
measure of the degree to which the score is able to dis-
criminate between persons in the given sample [28]. It
has been argued that Mokken scaling is a natural start-
ing point for item analysis, and it is used here in that
context, to identify if any items from the VLAs display a
level of discrimination inconsistent with the expectations
of the Rasch model, as represented by low values (< 0.3)
of H [29]. In the present study Mokken scaling is exam-
ined through the msp procedure in STATA 13 [30].
Rasch model
Data from the 33 items were fitted to the Rasch model
to ascertain if a quantitative structure was present within
the domain(s) being measured [31]. Described in detail
elsewhere [32], the process is used to test fit to the
model expectations, unidimensionality, (conditional) local
item independence and invariance (Differential Item Func-
tioning) by contextual groups of age, gender, employment
and marital status, duration of disease, and where data are
pooled, by condition [33, 34]. Briefly, the RUMM2030
Rasch software [35] has a summary Chi-Square Interaction
statistic, which should be above 0.05 if data fit the model. It
has residual item and person means and standard devia-
tions, the latter which need to below 1.4 to ensure no indi-
vidual item is beyond a ± 2.5 range. Reliability of the items
set was also reported in the form of a ‘person separation
Index’ which, should the data have a normal distribution, is
equivalent to Cronbach’s Alpha (internal consistency) [36],
else the value will deviate from Alpha. A post hoc t-test is
undertaken to determine unidimensionality, contrasting
two estimates derived from item sub-sets loading positive
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and negative on the first residual principal component [37].
The number of contrasts between estimates where the t-
test < 0.05 should not exceed 5% to be indicative of unidi-
mensionality (or the lower confidence interval of that
proportion of tests).
Following this, informed by the above analysis of 33
items, a calibration of the item set was attempted to
form the basis of a CAT. To avoid the potential bias
caused by a breach of the local independence assump-
tion, first a set of ‘core’ items that fit the model and were
free of local dependency were identified [38]. In doing so
surplus items were set aside into a series of secondary
item sets, which were subsequently fit to the model, an-
chored to the core metric by items in the core set which
were free of dependency. Fit of the core and subsequent
item sets to the Rasch model were tested by repeated
sampling of the total data set to ensure the Type 1 error
rate of the fit is accurate [39]. In this way, a calibrated
set of items became available that could be administered
in an innovative fashion by appropriate CAT software.
The efficacy of the CAT process was evaluated by simu-
lation using the Firestar programme [40].
The analysis uses the RUMM2030 software utilising the
partial credit parameterisation of the Rasch model [35, 41].
Results
Phase 1: cross-cultural adaptation
Cognitive debriefing interviews were conducted with 31
participants with RA whose socio-demographic and
health characteristics are detailed in Table 1.
Fig. 1 British VLAs Overall Recruitment & Study Progress Flow Diagram
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In general, all British English VLAs items were deemed
important and relevant. In terms of comprehensibility,
item 13 “going to social events, parties, or celebrations”
and item 18 “taking part in leisure activities OUTSIDE
your home, such as going to the pub, bingo, going to the
cinema, club meetings, restaurants” raised the question
whether these are measuring the same concept amongst
most participants (n = 21) as they required similar con-
siderations to be able to participate. For example, partic-
ipants noted participation depended on location and
accessibility. Several participants (n = 8) queried whether
item 21 [driving or getting around your community by
public transport] should be divided into separate items
as they perceived “driving” and “using public transport”
different transport options. However, when explained
that this item measures participation (i.e. at a societal
level) rather than activity limitation (i.e. at a personal
level) they did not think it needed to change. Two par-
ticipants suggested that item 27 (taking care of social
communication, such as writing letters, sending emails,
making phone calls or texting) could be separated into
verbal and written communication. However, as this was
raised by only two out of 31 participants, the original
item remained unchanged.
Participants also struggled with the question “Do you
have to make changes to how you do this activity be-
cause of your arthritis?” They were unclear whether to
tick ‘no’ or just leave it blank if ‘unable to do’ the activ-
ity. This issue was resolved by adding further instruc-
tions to the VLAs to aid responder’s decision making.
Item 33 “having intimate relations with your spouse/
partner” was perceived as too intrusive by some partici-
pants (n = 6). However, as the majority of the responders
found this item to be relevant and appropriate, the item
was retained.
Following the cognitive de-briefing interviews, no new
items were added. Instead, some changes were made to
the layout and wording of the items, so they are relevant
and comprehensible to the British population (Add-
itional File 2). The changes made were submitted to the
lead developer who agreed to these, as these were ac-
knowledged as differences in expression between North
American and British English.
Phase-2: psychometric testing
In Phase-2, 1929 NHS patients were screened, and a fur-
ther 3365 invitations were sent through Patient Organi-
sations (Fig. 1). From both of these sources, 1946 were
interested and eligible, of whom the most (97%) con-
sented; and 1546 (81%) returned the postal question-
naire. The participants’ socio-demographic and health
characteristics are detailed in Tables 1 and 2. The re-
sponse options to all 33 items are shown in Table 3, in-
cluding the percentage of those reporting that an item
“Does not apply to me”. Only 79 (5%) respondents com-
pleted all 33 items (including the “does not apply to me”
option).
Construct validity (confirmatory factor analysis and Mokken
scaling)
A Confirmatory Factor Analysis failed to support a uni-
dimensional scale from the 33-item VLAs (Chi Square
3552:df 464:p < 0.0001; RMSEA 0.066(90CI: 0.064–
0.068); CFI .985; TLI 0.984); the 25-item VLAs (Chi
Square 2836:df 275:p < 0.0001; RMSEA 0.078(90CI:
0.076–0.081); CFI .987; TLI 0.986; or the 14-item Short
VLAs version (Chi Square 1228:df 77:p < 0.0001; RMSEA
0.099 (90CI: 0.094–0.104). Based on the item classifica-
tion into the three domains (Obligatory, Committed,
Discretionary), the three-domain structure of the item
set also failed (Chi Square 2693:df 272: p < 0.0001;
RMSEA 0.076(90CI: 0.074–0.079);
CFI .987; TLI 0.986). Modification indices throughout
these analyses indicated substantial cross loading, par-
ticularly between Obligatory and Committed items, and
substantial local dependency among pairs of items, thus
requiring correlated errors. Given the ancillary fit statis-
tics were more supportive, the results suggest that the
disturbance of structure may be strongly influenced by
clusters of locally dependent items. A Loevinger Coeffi-
cient from Mokken scaling of 0.87 for all 33 items indi-
cated a strong non-parametric association between
items, and despite the lack of evidence of unidimension-
ality (which is an assumption of Mokken), provided suf-
ficient evidence to move forward to a Rasch analysis of
the data.
Rasch: diagnostics
Fit of the data from the VLAs to the Rasch model is
shown in Table 4. An initial Likelihood Ratio test to de-
termine if a Rating scale or Partial Credit parameterisa-
tion was appropriate supported the latter (Chi-Square
1281.3 (df 63); p = < 0.0001). For each of the eight condi-
tions, fit is shown for the 33, 25 and 14-item versions.
Only four analyses satisfied the stochastic ordering (fit)
and unidimensionality assumptions (AS-25; AS-14; SS-
25; PS-14). Even here, the local independence assump-
tion was breached by clusters of residual item correla-
tions, although of insufficient magnitude to affect the fit
and unidimensionality tests. Elsewhere, the VLAs was
characterised by multidimensionality and misfit, which
again may have been influenced by extensive clusters of
residual item correlations. While reliability was high in
all cases, this could be expected to be inflated in the
presence of local response dependency, as identified
through the residual correlation patterns. Differential
item function was occasionally present for age, gender
and marital status, but not for education or duration of
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condition. For example, “Doing heavy housework’ was
more difficult for females at any level of ability. DIF was
also present for condition in 15 of the 33 items. For ex-
ample, for those with RA, ‘traveling long distances’ was
more difficult than other conditions at all levels of life
activity. Likewise, ‘Taking care of social communication’
was more difficult for those with chronic hand/upper
limb conditions, at any level of life activity. Overall, the
easiest activities (difficulty rarely affirmed) were ‘eating’
and ‘taking part in leisure activities in the home’, while
the hardest activities (difficulty common) were ‘minor
home repairs’ and ‘gardening’.
The clusters of locally dependent items did not neces-
sarily conform to the Obligatory, Committed or Discre-
tionary domains. For example, in people with RA, the
items ‘doing other work around the house’ and ‘garden-
ing or outdoor property work’ were designated as
Committed and Discretionary respectfully, displayed a
residual correlation of 0.506 in the 33-item version, and
0.447 in the 25-item version. Nevertheless, fit to the
model constrained to within the domains showed some
improvement, although the occasional misfit and multi-
dimensionality remained (Table 5). This suggests that
much of the disturbance of fit and dimensionality could
be attributable to the local dependency issue.
An item Bank approach
Consequently, the item bank approach was applied. A
core set of 15 items were shown to fit the Rasch model
across most indicators (Table 6, Analyses 1–3). How-
ever, the item ‘Travelling long distances’ showed DIF by
condition with, for example, RA and OA showing dis-
tinct differences in expected response at any level of dif-
ficulty, the former having more difficulty than the latter
(Fig. 2). Having set aside the surplus items from the local
dependency analysis, a second item set was created with
10 items, which again showed fit to the model and no
DIF by condition (Table 6. Analyses 4–6). Thus, 25 of
the 33 items were available for CAT, and with the sec-
ond set calibration anchored by three items from the
core set, all items were calibrated onto the same unidi-
mensional interval scale metric. The mean number of
items chosen (i.e. excluding “does not apply to me” re-
sponses) from the VLA-CAT25 in the main data set was
17.4, and the maximum was 24 (3.5%) (Fig. 3). Simula-
tion of the efficacy of the CAT identified that for group
use the average number of items required to achieve an
alpha of ≥0.7 was 4, and 11 to achieve an alpha of 0.85
for individual use. Consequently, it would appear that
given the patient choice of relevant items, the CAT can
in most cases accommodate both individual and group
estimates with the required reliability, should the distri-
bution shown in Fig. 3 be replicated elsewhere.
Summary of the results
The 33-item VLAs was linguistically validated and cul-
turally adapted for British people aged ≥18 years with
RMDs following recommended guidelines. The British
English VLAs retained all of the original 33-items, with
some changes to the wording, template and instructions
to make it easily understandable by British people. Fol-
lowing this, the VLAs was tested in its 33, 26 and 14
item versions with British people across 8 different
RMDs to verify its psychometric validity and reliability
(internal consistency). The latter two versions were
nested within the 33-item version, with a minor change
to the 26-item version which had split an original item
into two parts. The results of the statistical analysis show
that the VLAs, in its various summated forms (i.e. add-
ing together items in complete sets scored using those
items identified as important to the person) was not a
Table 2 The British VLAs Participants’ Health Characteristics
AS
(n = 165)
OA
(n = 184)
SLE
(n = 164)
SS
(n = 170)
CP
(n = 194)
CH
(n = 157)
PSS
(n = 171)
RA
(n = 340)
HAQ20: 0–60
Median (IQR)
5.50
(1.00–14.00)
9.00
(4.00–19.50)
7.50
(2.00–21.0)
10.00
(30.00–20.00)
17.00
(8.25–28.00)
6.00
(1.00–15.00)
4
(0.25–13.00)
13.00
(4.00–23.00)
SF-36v2a
Physical Function
norm scored
43.64
(30.75–49.88)
36.49
(28.83–46.06)
36.26
(26.92–46.06)
36.49
(26.92–45.58)
30.75
(23.09–38.40)
46.06
(38.40–51.80)
40.32
(30.75–49.88)
36.49
(26.93–46.06)
SF-36v2a
Bodily Pain
norm scored
42.64
(34.58–50.71)
38.21
(30.55–42.64)
38.21
(30.55–46.68)
42.24
(38.21–49.90)
30.55
(26.52–38.21)
38.21
(33.27–62.00)
42.24
(38.21–51.51)
42.24
(34.18–47.48)
SF-36v2a
Vitality
norm scored
43.69
(37.74–49.63)
43.69
(34.77–52.60)
37.74
(31.80–46.66)
40.72
(34.03–49.63)
34.77
(25.86–43.69)
46.66
(37.74–52.60)
40.72
(31.80–49.63)
43.69
(34.77–49.63)
SF-36v2a
Mental Health
norm scored
48.25
(43.02–56.10)
48.25
(40.40–54.14)
45.64
(37.79–51.53)
48.25
(40.40–56.10)
43.02
(29.94–48.25)
48.25
(40.40–53.48)
45.64
(37.79–53.48)
50.8
(43.02–56.10)
Key: HAQ Health Assessment Questionnaire; aSF36v2 = Short Form 36v2 Median (IQR) 0–100; lower scores = better in HAQ20. SF36v2 scored using Quality Metric
Health Outcomes™ Scoring Software 4.5
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Table 3 Responses to the British VLAS (n = 1545)
Response option (%)
Item Without
Difficulty
Some
Difficulty
Much
Difficulty
Unable
to Do
Not Apply
1 Taking care of your basic needs, such as bathing, washing, getting
dressed or taking care of personal hygiene
48.0 39.0 8.4 1.5 3.1
2 Preparing meals and cooking 48.2 33.1 9.5 3.0 6.3
3 Doing light housework, such as dusting or laundry 51.8 30.2 8.0 2.6 7.4
4 Doing heavier housework, such as vacuuming, changing sheets, or
cleaning floors
24.5 32.8 21.7 12.9 8.2
5 Doing other work around the house, e.g. making minor home repairs or
working in the garage fixing things
15.5 15.4 7.4 16.4 45.2
6 Gardening or outdoor property work 16.3 29.3 13.5 15.0 26.0
7 Shopping and doing errands 40.7 34.1 13.7 5.7 5.9
8 Going to appointments, such as going to the doctor or dentist, or going
to have your hair cut or done
61.2 21.7 9.0 1.0 7.2
9 Taking care of young children in your family or doing things for them. 20.1 16.1 6.4 2.0 55.5
10 Taking part in activities with young children in your family 16.8 20.0 8.4 2.7 52.4
11 Taking care of other family members, such as your spouse or parent, or
other people close to you
30.1 19.0 6.9 4.2 39.8
12 Visiting friends or family members in their homes 58.1 23.2 6.3 2.7 9.7
13 Going to social events, parties, or celebrations 43.2 21.1 6.7 3.9 25.2
14 Having friends and family members visit you in your home 62.0 20.1 4.3 1.1 12.4
15 Walking or getting around INSIDE your home 63.7 27.6 5.1 0.4 3.2
16 Walking OUTSIDE, just to get around, in the area around your home or
other places you need to go on a regular basis (This does not include
walking for exercise)
53.6 28.9 11.7 2.0 3.8
17 Taking part in leisure activities IN YOUR HOME, such as reading, watching
television, listening to music
78.2 14.5 3.0 0.2 4.1
18 Taking part in leisure activities OUTSIDE your home, such as going to the pub,
bingo, going to the cinema, club meetings, restaurants
44.1 23.2 7.2 3.6 21.9
19 Working on hobbies, crafts, or creative activities, such as music, knitting,
sewing, woodworking, or painting
25.6 24.7 8.7 7.2 33.9
20 Taking part in physical recreational activities, such as walking for exercise,
dancing, playing golf, bicycling, swimming or water aerobics
20.9 31.7 12.9 15.0 19.5
21 Driving or getting around your community by public transport 53.9 26.5 6.7 2.8 10.2
22 Travelling long distances 52.7 23.7 10.5 3.9 9.2
23 Taking part in religious or spiritual activities or religious services 23.9 6.7 1.2 1.8 66.4
24 Doing volunteer work 16.6 7.6 1.6 5.1 69.1
25 Working at a job for pay 15.2 18.1 4.3 6.8 55.7
26 Taking care of household business, e.g. pay bills or scheduling repairs 66.8 14.2 3.9 1.0 14.1
27 Taking care of social communication such as writing letters, sending
e-mails, making phone calls or texting
63.5 24.3 5.3 0.8 6.1
28 Going to college or educational activities 11.2 3.1 1.3 2.2 82.2
29 Sleeping 27.8 45.8 22.3 0.8 3.3
30 Eating and chewing 75.0 16.4 4.1 0.0 4.5
31 Meeting new people 65.6 8.6 3.1 0.9 21.8
32 Having and/or taking care of a pet. 25.8 13.9 2.5 1.6 56.1
33 Having intimate relations with your spouse/partner 27.4 20.8 7.6 6.8 37.4
a Items in bold are those subsequently included in the VLAS-CAT25
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valid measure of valued life activities. Only 5% of the
sample considered all the items applied to them.
When a calibration was made for use in a CAT, 25 of
the 33 items were retained, and formed a valid unidi-
mensional item set, largely invariant by condition. The
CAT could provide sufficient reliability to accommodate
both individual and group estimates. Using suitable CAT
software, these items could be administered taking ac-
count of both the varying difficulty of the items, the
local dependency that exists, and the DIF on the ‘travel’
item, so giving an estimate of VLA on an 0–100 interval
scale, irrespective of the number of items chosen.
Discussion
The Valued Life Activities scale was completed by a
large number of people across eight RMDs. The VLAs
was perceived as a relevant and understandable measure
of activities and participation by British people with
RMDs. However, robust psychometric testing of the
British VLAs in the context of the current scoring
method (i.e. summing items identified as important to
the respondent only) of the 33, 25 and 14 item versions
showed that, due to local item dependency, multidimen-
sionality and misfit to Rasch model expectations, the
VLAs had insufficient validity to enable a recommenda-
tion for its use as summated item sets in clinical evalu-
ation or research. The usual strategy of scoring only
those items that apply to the individual does not exempt
the underlying item set from basic psychometric require-
ments, as the choices that are made deliver an almost in-
finite subset of items from the whole, each of which
should satisfy those same requirements.
The ‘Does not apply to me’ response also raises sub-
stantial problems with how these items are scored, and
how to deal with this response (in addition to any other
type of missingness). The problem is similar to that ob-
served for Goal Attainment Scaling where patients are
involved with the choice of goals for their rehabilitation
[42]. While Rasch analysis can deal with both structural
and ordinary missingness, and multiple imputation
Table 4 Rasch Analysis of Various Versions of the Scale by Condition
Condition and number of items Chi- Squarea Df P Residual Item Residual Person PSI Reliability % tests > 5% 95%CI N
Mean SD Mean SD
1 Ankylosing Spondylitis- 33 129.3 66 < 0.001 −0.5876 1.6027 −0.3703 1.0239 0.93 8.02 4.7–11.4 165
2 AS-25 54.0 50 0.324 − 0.4318 1.1425 − 0.3715 1.1252 0.92 7.64 4.2–11.1 165
3 AS-14 24.0 28 0.684 −0.3933 1.3061 − 0.4036 1.0915 0.90 5.73 2.3–9.1 165
4 Rheumatoid Arthritis-33 315.3 165 < 0.001 −0.3128 2.0134 −0.2709 1.0995 0.95 6.67 4.3–9.5 336
5 RA-25 214.2 200 0.233 −0.2082 1.5988 −0.3244 1.1197 0.95 10.64 8.3–13.0 336
6 RA-14 141.5 112 0.031 −0.2118 1.7771 −0.4067 1.1493 0.92 8.51 6.2–10.9 336
7 Chronic Pain −33 210.49 132 < 0.001 −0.2716 1.6226 −0.2152 1.2471 0.96 8.65 5.5–11.8 194
8 CP-25 121.7 100 0.069 −0.2432 1.3791 −0.2654 1.2142 0.96 9.73 6.6–12.9 194
9 CP-14 77.1 56 0.032 −0.1707 1.3792 −0.2721 1.1337 0.93 10.38 7.2–13.5 194
10 Chronic Hand/Upper Limb-33 145.9 66 < 0.001 −0.2638 1.7283 −0.2785 0.9902 0.91 7.95 4.5–11.4 157
11 CH-25 76.0 50 0.010 −0.1936 1.4952 − 0.3153 1.0373 0.91 8.61 5.1–12.1 157
12 CH-14 44.4 28 0.026 −0.1760 1.5444 −0.2875 0.8676 0.88 9.15 5.7–12.6 157
13 Osteoarthritis-33 156.4 99 < 0.001 −0.3829 1.4713 −0.2158 0.8122 0.94 10.92 7.7–14.2 184
14 OA-25 94.5 75 0.063 −0.3394 1.1947 −0.2598 0.8926 0.94 12..07 8.8–15.3 184
15 OA-14 52.3 42 0.133 −0.3406 1.1186 −0.2979 0.9932 0.91 12.07 8.8–15.3 184
16 Systemic Lupus −33 201.5 99 < 0.001 − 0.2439 1.7943 −0.1998 1.1412 0.94 6.17 2.8–9.5 164
17 SLE-25 148.7 75 < 0.001 −0.3171 1.4556 − 0.2224 1.0881 0.94 9.92 6.5–13.2 164
18 SLE-14 67.5 42 0.007 −0.2797 1.3644 −0.3106 1.1546 0.91 10.43 7.1–13.8 164
19 Systemic Sclerosis-33 214.7 99 < 0.001 −0.2154 1.7710 −0.2079 1.0446 0.91 6.21 2.7–9.8 170
20 SS-25 88.4 75 0.139 −0.1269 1.4387 −0.2573 1.0479 0.91 6.45 3.0–9.9 170
21 SS-14 45.7 42 0.321 −0.1567 1.2816 −0.3223 1.0401 0.87 8.43 5.1–11.7 170
22 Primary Sjogren’s-33 255.8 99 < 0.001 −0.3904 1.7979 −0.2317 1.1495 0.90 7.88 4.5–11.2 171
23 PS-25 138.8 75 < 0.001 −0.2100 1.2663 −0.3023 1.1632 0.90 4.85 1.5–8.2 171
24 PS-14 50.5 42 0.173 −0.1771 1.1396 −0.4102 1.1496 0.87 6.21 2.8–9.6 171
Ideal Values > 0.05a < 1.4 < 1.4 > 0.70 < 5.0 LCI < 5.0
aBonferroni Adjusted (for 33 & 25 items fit is 0.002; for 14 items is 0.004)
Prior et al. BMC Musculoskeletal Disorders          (2020) 21:505 Page 11 of 16
techniques can provide complete data sets, this is un-
likely to be available in routine clinical practice [43].
Also, imputation techniques are not designed to deal
with ‘missing not at random’ instances, which is likely to
be the case with the ‘does not apply to me’ option. Fur-
thermore, the usual strategy for scales to provide a
Table 5 Rasch Analysis of the Domain Scores
Condition and number
of items
Chi- Square* Df P Residual Item Residual Person PSI Reliability % tests > 5% 95% CI N of cases/items
Mean SD Mean SD
Rheumatoid Arthritis 336
1 Obligatory 31.6 25 0.171 −0.0025 0.7371 −0.3163 0.8669 0.79 1.84 0.0–4.2 5
2. Committed 41.3 40 0.415 −0.3659 0.8992 − 0.5156 1.2163 0.88 5.0 2.5–7.3 8
3. Discretionary 59.6 55 0.313 −0.3283 1.1107 −0.3196 0.8450 0.86 4.8 2.4–7.2 11
4 Activities 74.2 65 0.203 −0.3421 1.0915 −0.4057 1.1325 0.91 7.32 5.0–9.7 13
Ankylosing Spondylitis 165
5 Obligatory 32.5 35 0.590 −0.4068 0.9407 −0.4738 1.0066 0.70 3.75 1.0–8.5 5
6 Committed 22.4 24 0.558 −0.0942 0.9214 −0.3141 1.0133 0.86 5.63 2.2–9.0 8
7 Discretionary 43.2 33 0.110 −0.3089 1.3239 −0.3631 0.8425 0.82 5.63 2.2–9.0 11
8 Activities 98.7 117 0.888 −0.2960 0.8862 −0.3474 1.0455 0.89 4.94 1.6–8.3 13
Chronic Pain/FM 194
9 Obligatory 13.7 20 0.846 −0.0021 0.6141 −0.4108 1.1276 0.86 4.49 1.1–7.9 5
10 Committed 19.8 24 0.708 −0.2349 1.0388 −0.4173 1.1389 0.90 5.35 2.2–8.5 8
11 Discretionary 45.0 33 0.079 −0.4593 1.6245 −0.3326 0.9164 0.87 4.32 1.2–7.5 11
12 Activities 62.2 39 0.010 −0.2450 0.9657 −0.2855 1.1148 0.94 8.95 5.8–12.0 13
Chronic HUL 157
13 Obligatory 18.7 15 0.229 −0.3316 1.2499 − 0.3862 0.7203 0.50 2.65 0.0–6.1 5
14 Committed 26.0 24 0.355 −0.3128 1.5619 −0.4211 0.8959 0.88 7.52 3.8–11.2 8
15 Discretionary 32.8 33 0.475 −0.3164 0.9507 −0.4290 1.0548 0.76 3.42 0.0–6.6 11
16 Activities 50.2 39 0.108 −0.1920 1.5876 −0.3047 0.8493 0.88 7.24 3.8–10.7 13
Osteoarthritis 184
17 Obligatory 31.1 15 0.009 −0.0317 1.2638 −0.2855 0.8517 0.78 2.85 0.0–6.1 5
18 Committed 27.6 24 0.270 −0.3113 0.6352 −0.3043 0.8110 0.87 5.26 1.8–8.7 8
19 Discretionary 49.7 33 0.031 −0.4230 1.2061 −0.3355 0.8260 0.83 5.49 2.2–8.8 11
20 Activities 31.3 39 0.807 −0.3510 0.8760 −0.2667 0.8752 0.91 10.92 7.7–14.2 13
Systemic Lupus 164
21 Obligatory 15.2 15 0.440 −0.0414 0.5008 −0.3181 0.9331 0.77 3.07 0.0–6.4 5
22 Committed 22.4 24 0.558 −0.3746 0.9971 −0.4169 1.002 0.90 4.91 1.6–8.3 8
23 Discretionary 40.0 33 0.036 −0.3000 1.2608 −0.2669 0.8150 0.84 5.56 2.2–8.9 11
24 Activities 50.1 39 0.110 −0.5035 1.0784 −0.2664 0.9472 0.92 8.59 5.2–11.9 13
Systemic Sclerosis 170
25 Obligatory 23.4 15 0.075 −0.0035 1.4896 −0.2991 0.8805 0.62 3.00 0.0–6.3 5
26 Committed 25.2 24 0.395 −0.0556 0.8197 −0.3076 0.8682 0.86 3.03 0.0–6.4 8
27 Discretionary 46.2 33 0.063 −0.1914 1.4057 −0.2351 0.7523 0.80 2.45 −0.09-5.8 11
28 Activities 41.6 39 0.358 −0.1652 1.1150 −0.3109 0.9900 0.87 4.85 1.5–8.2 13
Primary Sjogren’s 171
29 Obligatory 12.2 10 0.273 0.0650 1.2408 −0.1897 0.9149 0.55 1.81 −1.5-5.1 5
30 Committed 31.8 24 0.131 −0.1624 0.9641 −0.4212 0.8971 0.85 2.45 −0.9-5.8 8
31 Discretionary 4.1 33 0.094 −0.1784 1.2859 −0.3196 0.8102 0.74 0.61 −2.7-3.9 11
32 Activities 46.6 39 0.189 −0.4608 1.1457 −0.4803 1.0434 0.86 3.03 0.0–6.4 13
Ideal Values > 0.05 < 1.4 < 1.4 > 0.70 < 5.0 LCI < 5.0
Prior et al. BMC Musculoskeletal Disorders          (2020) 21:505 Page 12 of 16
transformation table from raw score to interval scaled
Rasch metric would also not apply, as it is only valid in
the presence of complete data, which is not attainable
under the present scoring method. This also affected ac-
tions to remedy the effects of local dependency, that is
by creating ‘super items’ (testlets) by adding together
clusters of items, as the ‘Does not apply to me’ option
resulted in case-wise deletion at the testlet level. Given
these problems, it was not possible to test for DIF
cancellation at the scale level due to the restriction upon
creating testlets [44]. Furthermore, under the current
scoring method, DIF would have to be assessed across
all possible combinations of items to examine if any DIF
is observed, and would cancel across the chosen items,
given the person estimate would be re-estimated for
each unique combination of items.
Some of the above problems were accommodated
through a CAT design, identifying 25 items (in two sets
of 15 and 10) which demonstrated fit to the Rasch
model, including unidimensionality and invariance by
most contextual groups. The DIF by condition for the
‘travel’ item needed a condition-specific item location es-
timate for those conditions affected. The calibrated item
set, given suitable CAT software, could be administered
to patients, offering the option of ‘not important for me’
and ‘not applicable to me’.
Implications for clinical and research practice
The main implication for clinical and research practice
is that the implementation of the above solution requires
access to CAT software or some system to provide
CAT-based estimates, and appropriate IT infrastructure
at the clinic level, or at least that the patient has online
facilities at home. One application, the smartCAT sys-
tem, was designed to facilitate such an environment, but
requires on-line interaction with its server, which will re-
turn an estimate in real time to the source, including an
appropriate clinical setting, as required [45]. It can cope
with clusters of locally dependent items, and different
estimates to account for DIF where present. Another
CAT solution can be found with the Concerto software,
which is an open-source online adapting testing platform
https://concertoplatform.com/about [46]. The former
has a small charge per assessment, while the latter is
free, but psychometric and technical applications can be
supported as required for a fee. So, when suitable
Fig. 2 Comparison of RA & OA on response to traveling long distances
Table 6 Rasch Analysis of Computer Adaptive Testing item sets
Analysis Item Sets and samples Chi- Squarea Df P Residual
Item
Residual
Person
PSI
Reliability
% tests >5% 95%LCI N
SD SD
1 Core Set- CAT15 Sample 1 153.0 135 0.138 1.586 0.967 0.87 6.8 4.7 500
2 Core Set- CAT15 Sample 2 172.5 135 0.016 1.711 0.934 0.88 6.6 4.5 500
3 Core Set- CAT15 Sample 3 165.2 135 0.040 1.576 0.880 0.88 5.1 3.0 500
4 Second Set- CAT10 Sample 1 106.6 90 0.112 1.314 0.927 0.84 5.6 3.2 500
5 Second Set- CAT10 Sample 2 114.2 90 0.043 1.694 0.993 0.85 3.6 1.1 500
6 Second Set- CAT10 Sample 3 106.6 90 0.112 1.498 1.021 0.86 5.2 3.0 500
Ideal Values >0.05a <1.4 <1.4 >0.70 <5.0 <5.0
aBonferroni Adjusted (0.008 for 6 tests)
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software is available, using the VLAS in this manner ad-
dresses the EULAR recommendations of assessing pa-
tient’s preferences and priorities concerning the impact
upon their activities and participation.
Limitations
We only conducted cognitive debriefing interviews with
people with RA, predominantly from the North West
and Midlands regions of England, due to budget and
timeline constraints. However, we tested the psychomet-
ric properties of the VLAs amongst eight RMDs. Cogni-
tive debriefing with people with other RMDs may have
resulted in reduction or addition of new items to the
British VLAs.
We intended to also examine test-retest reliability.
After 4 weeks of completing the first questionnaire
booklet, participants were mailed a second including the
VLAs. However, as the Rasch analysis identified signifi-
cant challenges in calculating scores, we did not progress
to test this. There is no reason why a ‘stable’ respondent
should choose the same set of items, even within a short
time frame. Given the potential number of item sets that
could be chosen, the retest can only be done on those
who have completed exactly the same set of items across
time. The question then arises as to whether or not a
failure to choose the same set of items constitutes a lack
of test-retest reliability. Even where the same set of
items are chosen, given the possible number of combina-
tions available, each combination should have sufficient
cases for the analysis, as though they were distinct scales.
Further work is required to consider how test-retest reli-
ability may be undertaken in such circumstances.
The VLA-CAT25 item bank itself has only just been
developed within this study and will require further psy-
chometric testing and testing in clinical settings to ascer-
tain how well it works in a day-to-day setting. The
smartCAT software is at its Beta test stage but has been
trialled on a fatigue item bank in a clinical setting in
Sweden. It requires careful management of the CAT
process, assigning unique patient identifiers, setting up
CAT in clinic, or providing links and passwords for use
at home. Data protection must be considered as the esti-
mate itself is created on the smartCAT server located
outside of the European Union and delivered in real
time back to the source or designated setting. Decisions
need to be taken as to whether or not the estimate and
its associated patient identifier is stored on the foreign
server, or not. Similar software programmes are likely to
have the same requirements.
The simulation of fit to the Rasch model was not ideal.
For example, the distribution of 100 random samples
would give more accurate picture of fit of the item bank
item sets, rather than just three consecutive samples
with replacement. Unfortunately, this option is not avail-
able in the software used. Consequently, further work
would need to verify the 15 & 10 items set fit. It is not
possible to test the fit of the 25 items together, as the
second set holds items which were locally dependent
with the core set, and which would generate multidi-
mensionality and misfit.
Conclusions
The British version of the VLAs, across various scales,
failed to satisfy classical and modern psychometric stan-
dards as full item sets. A CAT solution was found that
Fig. 3 Distribution of items chosen from the VLAs-25 CAT item set
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would overcome these limitations and avoid using in-
appropriate mathematical operations to derive a VLAs
score. It provides a Rasch derived interval scaled esti-
mate of Valued Life Activities from the set of items
chosen by the participant. Increasingly available CAT
software is required to implement the item bank. Fur-
ther validation of the CAT application is required.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12891-020-03409-9.
Additional file 1. VLAs Published Versions and Psychometric Testing.
Additional file 2. Original VLAs items vs the British VLAs items.
Additional file 3. British Valued Life Activities Scale [British VLAs].
Abbreviations
AS: Ankylosing Spondylitis; CAT: Computer Adaptive Testing; CP: Chronic
Pain; CUL: Chronic Upper Limb Pain; CFI: Comparative Fit Index;
CFA: Confirmatory Factor Analysis; DIF: Differential Item Functioning;
DMARDs: Disease Modifying Anti-Rheumatic Drugs; EULAR: European League
Against Rheumatism; FM: Fibromyalgia; HAQ: Health Assessment
Questionnaire; NHS: National Health Service; NRS: Numeric Rating Scale;
PROMs: Patient Reported Outcome Measures; PSI: Person Separation Index;
PSS: Primary Sjogren’s Syndrome; RA: Rheumatoid Arthritis; OA: Osteoarthritis;
SF-36v2 : Short-Form 36; SD: Standard Deviation; SLE: Systemic Lupus
Erythematosus; SS : Systemic Sclerosis; TLI: Tucker Lewis Index; UK: United
Kingdom
Acknowledgements
The authors would like to thank: all the study participants for their time in
completing questionnaires; the expert panel members for their time and
advice: John Grogan (translator), Dr. Kris Hollands (Canadian-English speaking
researcher, University of Salford); Angela Jacklin (Rheumatology occupational
therapist, Mid Cheshire NHS Trust Hospitals); Graeme McLeish (English
language expert, Services for Export and Language, University of Salford);
Rachel Gill, Rachel Shuttleworth, Robert Peet and Kate Woodward-Nut (University
of Salford) for assistance with data collection and data entry; Dr. Lynne Goodacre
(North West Research Design Service) and Ruth Hawkins (patient research
partner) for their invaluable contribution. We also like to thank all the
Principal Investigators, rheumatology consultants, rheumatology and
research nurses, research facilitators, GPs, patient organisations and
occupational therapists assisting with participant recruitment and study
support at the participating sites: Prof Terry O’Neill, Ann McGovern, Jennifer
Green, Angharad Walker, Prof A Jones, Penny Storrs, Jennifer Green, Katherine
Kinsella (Salford Royal Hospital); Prof Ian Bruce, Lindsey Barnes, Elizabeth Beswick,
Sarah Evans (Manchester Royal Infirmary); Dr. Leena Dass, Dr. Sophia Naz, Lorraine
Lock, Dr. Neil Snowden, Denise McSorland, Linda Kent (North Manchester General
Hospital); Dr. Chris Deighton, Alison Booth, Jo Morris (Royal Derby Hospital);
Melanie Arundell, Victoria Jansen (Pulvertaft Hand Centre, Royal Derby Hospital);
Prof David Walsh, Debbie Wilson, Jayne Smith (Kings Mill Hospital, Sherwood
Forest Hospitals NHS Foundation Trust); Dr. Chetan Mukhtyar, Loretta Dean, Susan
Rowell, Karen Mills, Jane Leeder, Jennifer Perkins, Sarah Wace (Norfolk and Norwich
Hospitals); Dr. Bela Szenbenyi, Carol Gray (Diana Princess of Wales, Grimsby); Dr.
Mike Green, Anne Gill, Lisa Carr (York Hospital); Dr. Kirsten Mackay, Julie
Easterbrook, Liz Burnett, Melanie Stone, Usha Chandra, Patricia Pickford,
Christine Dixon (Torbay Hospital); Dr. Mike Green, Alison Miernik, Rachel
Bailey-Hague (Harrogate District Hospital); Mr. Niall Graham, Dr. Atheer
Al-Ansari, Dr. Catherine Whittall, Jayne Edwards, Julia Nicholas (Robert Jones & Ag-
nes Hunt Hospital, Oswestry); Dr. Wendy Holden, Janet Cushnaghan, Angie Demp-
ster, Hayley Paterson, Barbara King (Basingstoke and North Hampshire Hospital);
Mr. David Johnson, Lindsey Barber, Jan Smith (Stepping Hill Hospital); Dr. Karen
Douglas, Lucy Kadiki, Chitra Ramful, Daljit Kaur (Russell Hall Hospital, Dudley); Dr.
Anca Ghiurlic, Christine Graver (Royal Hampshire Hospital, Winchester); Dr. Frank
McKenna, Jane McConiffe (Trafford Hospitals); Dr. Sophia Naz and Lorraine Lock
(Fairfield Hospital); Darren Peters, Jayne Endicott, Jamie Currie (Royal Devon and
Exeter Hospital); Louise Hollister, Sarah Jervis, Dawn Simmons (Weston Hospital,
Weston-super-Mare); Andrew Makaka (Whitehills Health and Community Care
Centre, Forfar); Christine Duncan (Ninewells Hospital, Dundee); Sarah Jervis (Count-
ess of Chester Hospital); Sarah Collins, Maree Leavy (Aintree Hospital); Dr. CD
Ramesh, Dr. MM Aziz, Dr. M Page, Dr. SK Ali, Lesley Miller, Stephen Preston, April
Weaver (North Lancashire PCT); Dr. Wan-Fai Ng, Katie Hackett (Royal Victoria
Infirmary, Newcastle upon Tyne); Dr. Elizabeth Price, Susannah Pegler (Great
Western Hospital, Swindon); Dr. Simon Bowman (Queen Elizabeth Hospital,
Birmingham); Amanda Oswald, Pain Care Clinic Ltd., Hove, UK. UK patient
organisations: Chris Maker, Chair: Lupus UK; Sally Dickinson, Information
Officer, National Ankylosing Spondylitis Association; Anne Mawdsley, CEO:
Raynaud’s and Scleroderma Association; Kim Fligelstone, Chair, Scleroderma
Society; Dr. Adam Al-Kashi, Head of Research, Back Care Association;
Lyndsey Middlemiss, Chair, Fibroaction; Pam Stewart, Chair: Fibromyalgia
Association; Steve Fisher, Chair, RSI Action.
Availability of the data and materials
Data and materials can be accessed through a request from the lead author.
Authors’ contributions
Alison Hammond (AH) conceived the study and was the Chief Investigator.
AH, Yeliz Prior (YP), Alan Tennant (AT) and Sarah Tyson (ST) initiated the
study design. YP conducted the Phase-1 Cognitive Debriefing Interviews and
Content Analysis and facilitated the Phase-2 data collection. AT conducted
the Rasch analysis. All authors contributed to refinement of the study protocol
and approved the final manuscript.
Funding
This paper presents independent research funded by the Versus Arthritis
[Grant No: 20031] and United Kingdom Occupational Therapy Research
Foundation (UKOTRF). NHS service support costs were secured from the
Greater Manchester Comprehensive Local Research Network (the Lead
CLRN). The views expressed of the authors are not necessarily of those of
the NHS or the funder. The sponsor and the funding source had no role in
the design of this study, its execution, analyses, interpretation of the data, or
decision to submit results, apart from study oversight.
Ethics approval and consent to participate
As data were collected in two different studies, ethical approvals were
obtained from the NRES Committee North West (Greater Manchester North)
[12/NW/0841], the North West 9 (Greater Manchester West) Research Ethics
Committee [11/H1014/5] and the University of Salford Research Ethics Panel
prior to the start of the study. Approvals have been obtained from the
Research and Development departments and therapy service managers at
each hospital. Good Clinical Practice (GCP) and informed consent training
were completed by all Occupational Therapists and research facilitators
taking part in this study. Eligible participants had provided written, informed
consent prior to the commencement of the study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Centre for Health Sciences Research, University of Salford, Frederick Road
Campus, Brian Blatchford Building PO.50, Salford M6 6PU, UK. 2Leeds Institute
of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
3Division of Nursing, Midwifery and Social Work, University of Manchester,
Manchester, UK.
Received: 6 March 2020 Accepted: 8 June 2020
References
1. Al Maini M, Adelowo F, Al Saleh J, Al Weshahi Y, Burmester GR, Cutolo M,
Flood J, March L, McDonald-Blumer H, Pile K, et al. The global challenges
and opportunities in the practice of rheumatology: White paper by the
World Forum on Rheumatic and Musculoskeletal Diseases. Clin Rheumatol.
2015;34:819–29.
Prior et al. BMC Musculoskeletal Disorders          (2020) 21:505 Page 15 of 16
2. Taylor PC, Alten R, Gomez-Reino JJ, Caporali R, Bertin P, Sullivan E, Wood R,
Piercy J, Vasilescu R, Spurden D et al: Clinical characteristics and patient-
reported outcomes in patients with inadequately controlled rheumatoid
arthritis despite ongoing treatment. 2018.
3. Steen Pettersen P, Neogi T, Magnusson K, Hammer HB, Uhlig T, Kvien TK,
Haugen IK. Peripheral and central sensitization of pain in individuals with
hand osteoarthritis and associations with self-reported pain severity. Arthritis
Rheum. 2019;71:1070.
4. Dailey DL, Keffala VJ, Sluka KA. Do cognitive and physical fatigue tasks
enhance pain, cognitive fatigue, and physical fatigue in people with
fibromyalgia? Arthritis Care Res. 2015;67(2):288–96.
5. Bernard P, Hains-Monfette G, Atoui S, Kingsbury C. Differences in daily
objective physical activity and sedentary time between women with self-
reported fibromyalgia and controls: results from the Canadian health
measures survey. Clin Rheumatol. 2018;37(8):2285–90.
6. Geenen R, Overman CL, Christensen R, Asenlof P, Capela S, Huisinga KL,
Husebo MEP, Koke AJA, Paskins Z, Pitsillidou IA, et al. EULAR
recommendations for the health professional's approach to pain
management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis.
2018;77(6):797–807.
7. Katz PP, Morris A, Yelin EH. Prevalence and predictors of disability in valued
life activities among individuals with rheumatoid arthritis. Ann Rheum Dis.
2006;65(6):763–9.
8. Yelin E, Lubeck D, Holman H, Epstein W. The impact of rheumatoid arthritis
and osteoarthritis: the activities of patients with rheumatoid arthritis and
osteoarthritis compared to controls. J Rheumatol. 1987;14(4):710–7.
9. Katz PP, Yelin EH. Life activities of persons with rheumatoid arthritis with
and without depressive symptoms. Arthritis Care Res. 1994;7(2):69–77.
10. Katz PP. The impact of rheumatoid arthritis on life activities. Arthritis Care
Res. 1995;8(4):272–8.
11. Katz PP, Yelin EH. The development of depressive symptoms among
women with rheumatoid arthritis. The role of function. Arthritis Rheum.
1995;38(1):49–56.
12. Verbrugge LM, Jette AM. The disablement process. Soc Sci Med. 1994;
38(1):1–14.
13. Katz PP, Morris A. Use of accommodations for valued life activities: prevalence
and effects on disability scores. Arthritis Rheum. 2007;57(5):730–7.
14. Katz P, Morris A, Gregorich S, Yazdany J, Eisner M, Yelin E, Blanc P. Valued
life activity disability played a significant role in self-rated health among
adults with chronic health conditions. J Clin Epidemiol. 2009;62(2):158–66.
15. Neugebauer A, Katz PP, Pasch LA. Effect of valued activity disability, social
comparisons, and satisfaction with ability on depressive symptoms in
rheumatoid arthritis. Health Psychol. 2003;22(3):253–62.
16. Katz PP, Radvanski DC, Allen D, Buyske S, Schiff S, Nadkarni A, Rosenblatt L,
Maclean R, Hassett AL. Development and validation of a short form of the
valued life activities disability questionnaire for rheumatoid arthritis. Arthritis
Care Res. 2011;63(12):1664–71.
17. Forrest M, Andersen B. Ordinal scale and statistics in medical research. BMJ.
1986;292:537–8.
18. Ørnbjerg LM, Christensen KB, Tennant A, Hetland ML. Validation and
assessment of minimally clinically important difference of the unadjusted
health assessment questionnaire in a Danish cohort: uncovering ordinal
bias. Scand J Rheumatol. 2020;49(1):1–7.
19. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of
cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–91.
20. Acquadro C, Bayles A, Juniper E. Translating patient-reported outcome
measures: a multi-step process is essential. J Bras Pneumol. 2014;40(3):211–2.
21. Hammond A, Tennant A, Tyson SF, Nordenskiöld U, Hawkins R, Prior Y. The
reliability and validity of the English version of the evaluation of daily
activity questionnaire for people with rheumatoid arthritis. Rheumatology.
2015;54(9):1605–15 https://doi.org/10.1093/rheumatology/kev008.
22. Kirwan JR, Reeback JS. Stanford health assessment questionnaire modified
to assess disability in British patients with rheumatoid arthritis. Br J
Rheumatol. 1986;25(2):206–9.
23. Ware JE Jr. SF-36 health survey update. Spine. 2000;25(24):3130–9.
24. Linacre JM. Sample size and item calibration stability. Rasch Meas Trans.
1994;4:328.
25. Brown TA. Confirmatory factor analysis for applied research. 2nd ed:
Guildford Press; 2006.
26. Kline RB. Principles and practice of structural equation modeling. 3rd ed.
New York: Guildford Press; 2011.
27. Muthén LK, Muthén BO. Mplus user’s guide. 6th ed. Muthén & Muthén.: Los
Angeles; 1998-2011.
28. Christensen KB, Kreiner S. Monte Carlo tests of the Rasch model based on
scalability coefficients. Br J Math Stat Psychol. 2010 Feb;63(Pt 1):101–11.
29. Mokken RJ. Nonparametric models for dichotomous responses. In: Linden
WJ, Hambelton RK, editors. Handbook of modern item response theory.
New Yprk: Springer; 1997.
30. StataCorp. Stata statistical software: release 13. College Station:
StataCorp LP; 2013.
31. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology:
what is it and why use it? When should it be applied, and what should one
look for in a Rasch paper? Arthritis Rheum. 2007;57:1358–62.
32. Rasch G. Probabilistic models for some intelligence and attainment tests,
(Copenhagen, Danish Institute for Educational Research). [Expanded edition
(1980) with foreword and afterword by B.D. Wright]. Chicago: The University
of Chicago Press; 1960.
33. Tennant A, Penta M, Tesio L, Grimby G, Thonnard J-L, Slade A, Lawton G,
Simone A, Carter J, Lundgren-Nilsson A, Tripolski M, Ring H, Biering-
Sørensen F, Marincek C, Burger H, Phillips S. Assessing and adjusting for
cross cultural validity of impairment and activity limitation scales through
Differential Item Functioning within the framework of the Rasch model : the
Pro-ESOR project. Med Care. 2004;42:37–48.
34. Christensen KB, Makransky G, Horton M. Critical values for Yen’s Q3:
identification of local dependence in the Rasch model using residual
correlations. Appl Psychol Meas. 2017;41(3):178–94.
35. Andrich D, Sheridan BED, Luo G. RUMM2030: Rasch unidimensional models
for measurement. Western Australia: RUMM Laboratory; 2009.
36. Cronbach IJ. Coefficient alpha and the internal structure of tests.
Psychometrika. 1951;16:297–333.
37. Smith EV. Detecting and evaluation the impact of multidimensionality using
item fit statistics and principal component analysis of residuals. J Appl Meas.
2002;3:205–31.
38. Doğanay Erdoğan B, Elhan AH, Kaskatı OT, Öztuna D, Küçükdeveci AA,
Kutlay Ş, Tennant A. Integrating patient reported outcome measures and
computerized adaptive test estimates on the same common metric: an
example from the assessment of activities in rheumatoid arthritis. Int J
Rheum Dis. 2017;20(10):1413–25.
39. Hagell P. Testing rating scale unidimensionality using the principal
component analysis (PCA)/t-test protocol with the Rasch model: the
primacy of theory over statistics. Open J Stat. 2014;4:456–65.
40. Cho SW. Firestar: computerized adaptive testing simulation program for
polytomous item response theory models. Appl Psychol Meas. 2009;33:644.
41. Masters G. A Rasch model for partial credit scoring. Psychometrika. 1982;47:
149–74.
42. Tennant A. Goal attainment scaling: Current methodological issues. Disabil
Rehabil. 2007;29:20–1.
43. Fellinghauer CS, Prodinger B, Tennant A. The impact of missing values and
single imputation upon Rasch analysis outcomes: a simulation study. J Appl
Meas. 2018;19(1):1–25.
44. Wyse AE. DIF cancellation in the Rasch model. J Appl Meas. 2013;14(2):
118–28.
45. Elhan AH, Oztuna D, Kutlay S, Kucukdeveci AA, Tennant A. An initial
application of computerized adaptive testing (CAT) for measuring disability
in patients with low back pain. BMC Musculoskelet Disord. 2008;9:166.
46. Scalise K, Allen DD. Use of Open-Source Software for Adaptive
Measurement: Concerto as an R-based Computer Adaptive Development
and Delivery Platform. Br J Math Stat Psychol. 2015;68(3):478–96.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Prior et al. BMC Musculoskeletal Disorders          (2020) 21:505 Page 16 of 16
